Exodus Point Capital Management, LP Ocular Therapeutix, Inc Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$3.14 - $5.04 $309,045 - $496,046	98,422 New	98,422 $309,000
Q3 2022 Nov 10, 2022	BUY	$4.09 - $6.5 $54,814 - $87,113	13,402 New	13,402 $56,000
Q2 2022 Aug 19, 2022	SELL	$3.01 - $5.22 $34,031 - $59,017	-11,306 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.83 - $7.35 $54,607 - $83,099	11,306 New	11,306 $56,000
Q4 2021 Feb 11, 2022	SELL	$6.16 - $12.07 $84,157 - $164,900	-13,662 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $34,541 - $51,064	3,561 Added 35.25%	13,662 $137,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $135,656 - $193,535	10,101 New	10,101 $143,000

151

136M

86.4K

263K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.